Live Breaking News & Updates on Bring Longitudinal Health Data

Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. As a spinoff from Intermountain Health, Culmination Bio maintains exclusive rights to a physical library and cloud-based data lake covering over 40 years of de-identified patient electronic health records and biospecimen data. As the most extensive data lake of its kind, it. ....

United States , David Reese , Melissa Mowery , Davidm Rubin , Merck Global Health Innovation Fund , Intermountain Health , Culmination Bio Raises , From Amgen Ventures , Bring Longitudinal Health Data , Culmination Bio , Intelligence Platform , Managing Director , Merck Global Health Innovation , Press Release Image , Intermountain Health , Isease Agnostic , Cloud Based , Are Identified , Press Release , Ews Release ,